Kite Pharma, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Two
Kite Pharma, Inc. had Finite-Lived Intangible Asset, Expected Amortization, Year Two of $1.07 million as of 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo · last filed 2017-02-28
- 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $1.07M.
- 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $4.18M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Two |
|---|---|
| 2016-12-31 | $1.07M 10-K · filed 2017-02-28 |
| 2015-12-31 | $4.18M 10-K · filed 2016-02-29 |